US › Healthcare

Beta Bionics, Inc. Common Stock (BBNX)

US · Healthcare · Medical Devices

$14.57+9.14%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$32.0M
Revenue YoY
+37.8%
Net profit
$-23.4M
Profit YoY
-38.7%
EPS
$-0.39
EPS estimate
$-0.62
Net margin
-73.1%

EPS came in at -0.39 against a street estimate of -0.62 — a beat of 37.1%.

Key statistics

Market cap
$600.6M
Forward P/E
0.0
P/B
2.25
Book value
$5.70
EPS (TTM)
$-1.60
52-week high
$32.71
52-week low
$8.80
50-day MA
$14.79
200-day MA
$17.57

Analyst view

Analysts rate Beta Bionics, Inc. Common Stock a buy (5 buy, 2 hold, 0 sell out of 7) with an average price target of $20.00.

Shareholding

Insiders
1.09%
Institutions
118.62%

Largest institutional holders

FundStake
Eventide Asset Management, LLC13.34%
Soleus Capital Management, L.P.9.77%
Morgan Stanley - Brokerage Accounts9.49%
Sands Capital Ventures, LLC8.32%
Farallon Capital Management, L.L.C.8.10%
BlackRock Inc6.82%
Point72 Asset Management, L.P.5.67%
Vanguard Group Inc4.98%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Beta Bionics, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.